Anatomic Repartition of 68Ga-PSMA-11–Positive Findings and Outside Planning Volumes Based on RTOG Consensus CTVs
| Site | PSMA-11–positive patients (n) | Outside CTV patients (n) | PSMA-11–positive lesions (n) | Outside CTV lesions (n) | Median size (mm)* | Median SUVmax* |
| Overall | 132 (49%) | 52 (19.5%) | 304 | 119 | 6.0 (3.0–23.0) | 5.7 (0.5–86.9) |
| Prostate bed (T+) | 47 (17.5%) | 1 (0.003%) | 52 | 1 | 7.0 (4.0–23.0) | 6.4 (2.2–86.9) |
| Pelvic LN (N+) | 83 (30.5%) | 30 (11%) | 174 | 39 | 6.0 (3.0–17.0) | 5.8 (1.5–69.7) |
| Internal iliac | 27 (10%) | 2 (0.7%) | 32 | 2 | 6.0 (3.0–10.0) | 7.3 (2.3–55.0) |
| External Iliac | 38 (14%) | 9 (3.5%) | 45 | 9 | 7.0 (3.5–15.0) | 5.9 (1.5–69.7) |
| Obturator | 19 (7%) | 2 (0.7%) | 24 | 2 | 6.0 (4.0–17.0) | 3.5 (2.1–17.4) |
| Perirectal | 18 (6.5%) | 16 (6%) | 25 | 19 | 5.0 (4.0–10.0) | 5.2 (1.50–57.7) |
| Presacral | 13 (5%) | 3 (1%) | 22 | 4 | 6.0 (4.0–10.0) | 7.5 (1.5–45.7) |
| Common iliac | 16 (6%) | 2 (0.7%) | 26 | 3 | 6.0 (3.0–15.0) | 5.9 (2.0–33.3) |
| Extrapelvic LN (M1a) | 9 (3.5%) | 9 (3.5%) | 28 | 28 | 8.0 (3.0–12.0) | 13.6 (2.7–38.9) |
| Inguinal | 2 (0.7%) | 2 (0.7%) | 7 | 7 | — | — |
| Retroperitoneal | 6 (2%) | 6 (2.2%) | 15 | 15 | — | — |
| Upper diaphragm | 2 (0.7%) | 2 (0.7%) | 6 | 6 | — | — |
| Bone (M1b) | 23 (8.5%) | 23 (8.5%) | 39 | 39 | — | 5.3 (2.7–28.8) |
| Lung (M1c) | 3 (1%) | 3 (1%) | 11 | 11 | 5.0 (4.0–7.0) | 1.0 (0.5–2.6) |
↵* Data in parentheses are range.
Percentages do not add up to 100 because multiple disease localizations per patient were possible.